BUPRENORPHINE 8 MG TABLET SL

Buprenorphine
$0.5567per EA
DEA Schedule CIII

Strength

8 mg/1

Manufacturer

AvPAK

NDC

50268012915

Classification

Generic

Dosage Form

TABLET

Route

SUBLINGUAL

Last Updated

4/22/2026

Active Ingredients

BUPRENORPHINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA201760

On Market Since

3/19/2024

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

-5.2%

3M

-15.9%

6M

-21.7%

1Y

-26.9%

3Y

N/A

5Y

N/A

All

-21.1%